Brownfield vs. Greenfield Facilities in Pharma

The onset of a global pandemic and other factors are causing many U.S.-based pharmaceutical and medical device companies to evaluate whether to bring back manufacturing facility operations they’ve previously outsourced to other countries. In a time where ensuring quality is paramount, insourcing has the potential to allow these organizations to implement more stringent quality control … Continue reading Brownfield vs. Greenfield Facilities in Pharma